| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-05 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-05 |